Competition is supposed to keep prices down, so why did the cost of emergency allergy treatment EpiPen continue to soar after the introduction of a competing product? Because, according to a new lawsuit, most of that added money was going to intermediaries who could make sure that EpiPen remained the preferred (and sometimes only) drug of its kind on insurance plans. [More]
the epipen is mightier than the sword
Lawsuit: EpiPen Price Hikes Were Intended To Keep Competitor Out Of Pharmacies
By 4.26.17 — Updated: 5.9.17
